Tuesday, 24 January 2017

Ajanta Pharma Q3 net rises 25% at Rs 142.6 cr

SHARE and STOCK MARKET calls and INTRADAY tips click here to subscribe FREE http://www.ripplesadvisory.com/free-trial.php

Drug maker Ajanta Pharma Ltd on Tuesday reported a rise of 25.2 per cent in its consolidated net profit after tax at Rs 142.6 crore for the third quarter ended December 31, 2016. “The consolidated net profit of the company stood at Rs 113.94 crore during the same period a year ago,” said Ajanta Pharma Ltd in a filing to the BSE on January 24, 2017. 

Further, the consolidated total income of the company increased by 15.3 per cent to Rs 552.3 crore during Q3 2016-17, from Rs 478.96 crore during the same period a year ago. The EBITDA of the company grew by 9 per cent at Rs 178 crore during Q3 2016-17, as against Rs 164 crore during the same period last fiscal.

No comments:

Post a Comment